Urban, Szymon
Szymański, Oskar
Grzesiak, Magdalena
Tokarczyk, Wojciech
Błaziak, Mikołaj
Jura, Maksym
Fułek, Michał
Fułek, Katarzyna
Iwanek, Gracjan
Gajewski, Piotr
Ponikowski, Piotr
Biegus, Jan
Zymliński, Robert
Article History
Received: 15 January 2024
Accepted: 31 May 2024
First Online: 5 June 2024
Competing interests
: Conflict of interest: Prof. Piotr Ponikowski has received personal fees for consultancy and Speakers Bureau from AstraZeneca, Boehringer Ingelheim, Vifor Pharma, Servier, Bayer, Bristol Myers Squibb, Respocardia, Berlin-Chemie, Cibiem, Novartis, and Renal Guard; other support for participation in clinical trials from Boehringer Ingelheim, Amgen, Vifor Pharma, Bayer, Bristol Myers Squibb, Cibiem, Novartis, and RenalGuard; and research grants to his institution from Vifor Pharma. All other authors have no conflicts of interest to declare that are relevant to the content of this article.